NEVUS, PORT-WINE

Clinical trials for NEVUS, PORT-WINE explained in plain language.

Never miss a new study

Get alerted when new NEVUS, PORT-WINE trials appear

Sign up with your email to follow new studies for NEVUS, PORT-WINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for rare, dangerous blood vessel tumors after other drugs fail

Disease control Not yet recruiting

This study is testing a drug called everolimus for people with rare, non-cancerous blood vessel growths and tumors that have not improved with standard treatments. It will enroll 67 patients, including children as young as 1 year old, who have already tried at least one other the…

Matched conditions: NEVUS, PORT-WINE

Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

NEVUS, PORT-WINE

Get alerted when new NEVUS, PORT-WINE trials appear

New hope for rare, dangerous blood vessel tumors after other drugs fail